EFFECTIVENESS OF LIFESTYLE MODIFICATION VS. PHARMACOLOGIC TREATMENT IN STAGE 1 HYPERTENSION
DOI:
https://doi.org/10.71000/4eh0ts60Keywords:
Stage 1 Hypertension, , Lifestyle Modification, Antihypertensive Therapy, Blood Pressure, Cardiovascular Risk, , Systematic ReviewAbstract
Background: Stage 1 hypertension is a prevalent cardiovascular risk factor, affecting a significant proportion of the adult population worldwide. While both lifestyle modification and pharmacologic therapy are endorsed in clinical guidelines, the optimal approach for initial management in patients without comorbidities remains unclear. Existing literature often evaluates these interventions separately, lacking direct comparisons specific to early-stage hypertension.
Objective: This systematic review aims to evaluate and compare the effectiveness of lifestyle modification versus pharmacologic treatment in reducing blood pressure and preventing cardiovascular events in adults with stage 1 hypertension.
Methods: A systematic review was conducted following PRISMA guidelines. Four databases—PubMed, Scopus, Web of Science, and Cochrane Library—were searched for articles published between January 2019 and April 2024. Eligible studies included randomized controlled trials and prospective cohort studies comparing lifestyle interventions (e.g., diet, exercise, weight loss) with antihypertensive medications in adults with stage 1 hypertension. Data extraction and risk of bias assessments were performed independently by two reviewers using standardized tools (Cochrane RoB 2 and Newcastle-Ottawa Scale).
Results: Eight studies involving 3,846 participants were included. Pharmacologic treatments resulted in faster and slightly greater reductions in systolic and diastolic blood pressure (mean SBP reduction: 9–14 mmHg; p < 0.001), while lifestyle interventions produced sustained, clinically meaningful reductions (mean SBP reduction: 6–11 mmHg; p < 0.05). Four studies reported reduced cardiovascular event rates in lifestyle groups over extended follow-up periods. Risk of bias was generally low to moderate across studies.
Conclusion: Both lifestyle modification and pharmacologic therapy are effective in managing stage 1 hypertension. Lifestyle interventions offer additional long-term cardiovascular benefits and may serve as a preferred initial strategy in select patients. Further large-scale, long-duration comparative trials are needed to reinforce these findings.
References
Duiyimuhan G, Maimaiti N. The association between atherogenic index of plasma and all-cause mortality and cardiovascular disease-specific mortality in hypertension patients: a retrospective cohort study of NHANES. BMC Cardiovasc Disord. 2023;23(1):452.
Abe T, Okuyama K, Kamada M, Kitayuguchi J, Hamano T, Waki H, et al. Association between flexibility activity and blood-pressure change among older adults in Japan: A 5-year longitudinal study. Scand J Med Sci Sports. 2023;33(8):1552-9.
Lu Q, Zhang Y, Geng T, Yang K, Guo K, Min X, et al. Association of Lifestyle Factors and Antihypertensive Medication Use With Risk of All-Cause and Cause-Specific Mortality Among Adults With Hypertension in China. JAMA Netw Open. 2022;5(2):e2146118.
Muscat DM, Morris GM, Bell K, Cvejic E, Smith J, Jansen J, et al. Benefits and Harms of Hypertension and High-Normal Labels: A Randomized Experiment. Circ Cardiovasc Qual Outcomes. 2021;14(4):e007160.
Grundler F, Mesnage R, Michalsen A, Wilhelmi de Toledo F. Blood Pressure Changes in 1610 Subjects With and Without Antihypertensive Medication During Long-Term Fasting. J Am Heart Assoc. 2020;9(23):e018649.
Park S, Han K, Lee S, Kim Y, Lee Y, Kang MW, et al. Cardiovascular or mortality risk of controlled hypertension and importance of physical activity. Heart. 2021;107(18):1472-9.
Gandotra C, Basam M, Mahajan A, Ngwa J, Ortega G, Tran D, et al. Characteristics and resolution of hypertension in obese African American bariatric cohort. Sci Rep. 2021;11(1):1683.
Ritchey M, Thompson-Paul A, Park S, Loustalot F, Hong Y, Jackson S. Characteristics of US adults who would be recommended for lifestyle modification without antihypertensive medication to manage blood pressure. American journal of hypertension. 2020.
Pires NF, Coelho-Júnior HJ, Gambassi BB, de Faria APC, Ritter AMV, de Andrade Barboza C, et al. Combined Aerobic and Resistance Exercises Evokes Longer Reductions on Ambulatory Blood Pressure in Resistant Hypertension: A Randomized Crossover Trial. Cardiovasc Ther. 2020;2020:8157858.
Ørbæk Andersen M, Diederichsen SZ, Svendsen JH, Carlsen J. Continuous heart monitoring to evaluate treatment effects in pulmonary hypertension. Open Heart. 2024;11(1).
Zhang Y, Nie J, Zhang Y, Li J, Liang M, Wang G, et al. Degree of Blood Pressure Control and Incident Diabetes Mellitus in Chinese Adults With Hypertension. J Am Heart Assoc. 2020;9(16):e017015.
Towfighi A, Cheng EM, Ayala-Rivera M, Barry F, McCreath H, Ganz DA, et al. Effect of a Coordinated Community and Chronic Care Model Team Intervention vs Usual Care on Systolic Blood Pressure in Patients With Stroke or Transient Ischemic Attack: The SUCCEED Randomized Clinical Trial. JAMA Netw Open. 2021;4(2):e2036227.
Wang Y, Feng L, Zeng G, Zhu H, Sun J, Gao P, et al. Effects of Cuisine-Based Chinese Heart-Healthy Diet in Lowering Blood Pressure Among Adults in China: Multicenter, Single-Blind, Randomized, Parallel Controlled Feeding Trial. Circulation. 2022;146(4):303-15.
Araújo TP, Borges LGS, Barroso WKS, Brandão AA, Barbosa ECD, Feitosa ADM, et al. Factors associated with uncontrolled blood pressure in hypertensive Brazilians. J Clin Hypertens (Greenwich). 2022;24(7):814-24.
Chaudhary A, Chaudhary B. Hypertension and Lifestyle Modifications: Beyond Controversy. Journal of Advances in Medicine and Medical Research. 2022.
McLellan HL, Dawson EA, Eijsvogels TMH, Thijssen DHJ, Bakker EA. Impact of Hypertension on the Dose-Response Association Between Physical Activity and Stroke: A Cohort Study. Stroke. 2024;55(9):2231-9.
Nikolaidou B, Anyfanti P, Vamvakis A, Zebekakis P, Tzimos C, Koletsos N, et al. Impact of Intensive Lifestyle Treatment (Diet Plus Exercise) on Endothelial and Vascular Function, Arterial Stiffness and Blood Pressure in Stage 1 Hypertension: Results of the HINTreat Randomized Controlled Trial. Nutrients. 2020;12.
Shamsi SA, Salehzadeh M, Ghavami H, Asl RG, Vatani KK. Impact of lifestyle interventions on reducing dietary sodium intake and blood pressure in patients with hypertension: A randomized controlled trial. Turk Kardiyol Dern Ars. 2021;49(2):143-50.
Elmahdy MA, Eldawa A-EAE, Zidan SYE, Elawady M, Elgendy MF. Lifestyle Modification and Its Effect on The Control of Hypertension. The Egyptian Journal of Hospital Medicine. 2022.
Newberg A, Cohen D, Fisher S, Detre J, Bhavsar R, Rao H, et al. Lifestyle Modification in Blood Pressure Study II (LIMBS): study protocol of a randomized controlled trial assessing the efficacy of a 24 week structured yoga program versus lifestyle modification on blood pressure reduction. Contemporary clinical trials. 2013;36 1:32-40.
Pasha M, Buda K, Hooker A. Managing stage 1 hypertension: Consider the risks, stop the progression. Cleveland Clinic Journal of Medicine. 2022;89:244-8.
Kamran S, Rashid H, Khan T, Nawaz S, Baqar S, Shah K, et al. Non-pharmacological management of hypertension: in the light of current research. Irish Journal of Medical Science (1971 -). 2018;188:437-52.
Najafi F, Darbandi M, Rezaeian S, Hamzeh B, Moradinazar M, Shakiba E, et al. Relative Handgrip Strength and Incidence of Hypertension: A Case-Cohort Study From Ravansar Non-Communicable Diseases Cohort. J Phys Act Health. 2022;19(10):666-72.
Whitaker K, Rogers E, Banks N, Jenkins N, Stanhewicz A. Resistance exercise lowers blood pressure and improves vascular endothelial function in individuals with elevated blood pressure or stage I hypertension. American journal of physiology Heart and circulatory physiology. 2023.
Heinonen S, Saarinen T, Meriläinen S, Sammalkorpi H, Penttilä AK, Koivikko M, et al. Roux-en-Y versus one-anastomosis gastric bypass (RYSA study): weight loss, metabolic improvements, and nutrition at 1 year after surgery, a multicenter randomized controlled trial. Obesity (Silver Spring). 2023;31(12):2909-23.
Rosenberg DE, Zhu W, Greenwood-Hickman MA, Cook AJ, Florez Acevedo S, McClure JB, et al. Sitting Time Reduction and Blood Pressure in Older Adults: A Randomized Clinical Trial. JAMA Netw Open. 2024;7(3):e243234.
Krumholz HM, de Lemos JA, Sattar N, Linetzky B, Sharma P, Mast CJ, et al. Tirzepatide and blood pressure reduction: stratified analyses of the SURMOUNT-1 randomised controlled trial. Heart. 2024;110(19):1165-71.
Desai AS, Webb DJ, Taubel J, Casey S, Cheng Y, Robbie GJ, et al. Zilebesiran, an RNA Interference Therapeutic Agent for Hypertension. N Engl J Med. 2023;389(3):228-38.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Urooj Nasir, Abdullah Humayun, Syed Hassan Ali Zaidi, Rabia Jalali, Iram Saddiqa Aamir , Muhammad Naeem (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
